Sherine Hassey
Family · Dracut, MANPI 1003047473
Payments from drug & device makers
Across 87 payments — averaging $19.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$278
- Pfizer$246
- AstraZeneca$232
- Otsuka America Pharmaceutical, Inc.$199
- Astellas Pharma US Inc$121
- Bayer$114
- plus $543 from 12 others
What the payments were for
- Food & beverage$1,733100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $278 |
| Pfizer | 12 | $246 |
| AstraZeneca | 12 | $232 |
| Otsuka America Pharmaceutical, Inc. | 10 | $199 |
| Astellas Pharma US Inc | 5 | $121 |
| Bayer | 6 | $114 |
| Lilly USA, LLC | 5 | $104 |
| Novo Nordisk | 5 | $103 |
| GSK | 4 | $86 |
| Nestle Healthcare Nutrition Inc. | 2 | $47 |
| Exact Sciences | 2 | $45 |
| Amarin Pharma, Inc. | 3 | $45 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Merck | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$1,733 in reported general payments places this provider in the 85th percentile of 2,320 family providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 15 | $14,286 |
| EliquisApixaban | 20 | $11,591 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,071 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,883 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 76 | $1,840 |
| Omeprazole | 88 | $1,793 |
| Levothyroxine Sodium | 123 | $1,691 |
| Atorvastatin Calcium | 90 | $1,242 |
| Metoprolol Succinate | 43 | $1,184 |
| Simvastatin | 125 | $1,171 |
| Lisinopril | 104 | $727 |
| Lubiprostone | 12 | $689 |
| ClopidogrelClopidogrel Bisulfate | 31 | $641 |
| Tamsulosin Hcl | 20 | $512 |
| Gabapentin | 20 | $491 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $246 | $11,59120 claims |
| GSKTrelegy Ellipta | $86 | $8,07113 claims |
| AstraZenecaSymbicort | $232 | $2,88312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,320 family providers in Massachusetts.
Other family in Dracut
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Courtney NixonAmherst$81K
- Elizabeth WalshBrighton$80K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.